| Blinatumomab studied in …STUDIED_INderived141 of 141show fewer |
|---|
| → studied in | NCT03739814Phase 2 · recruiting Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02458014Phase 2 · completed Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317662Phase 2 · recruiting Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · 141 trials list this drug (84 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570173Phase 2/Phase 3 · recruiting A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005) · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840976Phase 2 · not yet recruiting Immunotargeted Therapy Plus Low-Dose Chemotherapy in Newly Diagnosed Adult Ph+ B-ALL · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645718Phase 2 · recruiting Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia · 141 trials list this drug (84 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06308588Phase 1/Phase 2 · recruiting Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02003222Phase 3 · active not recruiting Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223190Phase 3 · not yet recruiting A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07178912Phase 2 · not yet recruiting Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387926Phase 1/Phase 2 · recruiting Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07003737NA · recruiting Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04546399Phase 2 · recruiting A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530565Phase 3 · active not recruiting Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · 141 trials list this drug (84 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02879695Phase 1 · active not recruiting Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147612Phase 2 · active not recruiting Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07604233Phase 1/Phase 2 · not yet recruiting Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML · 141 trials list this drug (84 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153796Phase 1/Phase 2 · active not recruiting A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227584Phase 2 · recruiting ALL Backbone in AYAs · 141 trials list this drug (84 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04307576Phase 3 · recruiting A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07192237Phase 2 · not yet recruiting Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283640Phase 1 · not yet recruiting A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07313852Phase 1/Phase 2 · not yet recruiting A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287229Phase 1/Phase 2 · recruiting Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07495631NA · recruiting Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143414Phase 2 · active not recruiting Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914625Phase 3 · active not recruiting A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101853Phase 3 · active not recruiting Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764238Phase 2/Phase 3 · recruiting Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493161NA · recruiting Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723911Phase 3 · not yet recruiting A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533748Phase 2 · recruiting Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371630Phase 1/Phase 2 · recruiting Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,Burkitt Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07133997Phase 1 · recruiting Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327894Phase 3 · recruiting Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03114865Phase 1/Phase 2 · active not recruiting A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677878Phase 1 · recruiting Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994717Phase 3 · active not recruiting Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393859Phase 3 · completed Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07643103Phase 2 · not yet recruiting Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02997761Phase 2 · completed Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636564Phase 2 · not yet recruiting Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment · 141 trials list this drug (84 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848687Phase 1/Phase 2 · recruiting TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052370Phase 1 · recruiting TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies · 141 trials list this drug (84 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04521231Phase 1/Phase 2 · active not recruiting A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02877303Phase 2 · recruiting Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263572Phase 2 · recruiting Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07134088Phase 1/Phase 2 · active not recruiting A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649006Phase 1 · completed Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) · 141 trials list this drug (84 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454226NA · recruiting ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573670Phase 2 · not yet recruiting A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia · 141 trials list this drug (84 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872790Phase 1 · active not recruiting Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07564453Phase 2 · recruiting Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05519579Phase 2 · recruiting Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222579Phase 2 · recruiting Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) · 141 trials list this drug (84 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329325Phase 2 · active not recruiting Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476729Phase 3 · not yet recruiting International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063317Phase 1 · terminated A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) · 141 trials list this drug (84 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07294677Phase 1/Phase 2 · recruiting CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL · 141 trials list this drug (84 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991920NA · not yet recruiting Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06054113Phase 2 · active not recruiting Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297914Phase 2/Phase 3 · not yet recruiting Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06387121Phase 2 · recruiting Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568553Phase 1 · completed Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma · 141 trials list this drug (84 active) | — | — | Non-Hodgkin Lymphoma,Mediastinal Lymphoma,Small Lymphocytic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03160079Phase 1/Phase 2 · completed Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts · 141 trials list this drug (84 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04260022Phase 1 · recruiting Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL · 141 trials list this drug (84 active) | — | — | Leukemia,Myeloid Leukemia,B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03595917Phase 1 · recruiting ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03480438Phase 2 · completed Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192889Phase 1/Phase 2 · active not recruiting Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882057Phase 2/Phase 3 · recruiting Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02790515Phase 2 · active not recruiting Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation · 141 trials list this drug (84 active) | — | — | Myeloid Sarcoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05182385Phase 1/Phase 2 · active not recruiting Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04827745Phase 2 · completed Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL · 141 trials list this drug (84 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03512405Phase 1/Phase 2 · active not recruiting Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811679Phase 2 · terminated A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma · 141 trials list this drug (84 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04506086Phase 4 · terminated Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04556084Phase 2 · terminated Blinatumomab Bridging Therapy for BALL · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06061094Phase 2 · recruiting Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643276Phase 3 · recruiting Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 · 141 trials list this drug (84 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06836973Phase 2/Phase 3 · not yet recruiting Blinatumomab for Treatment of Refractory Myasthenia Gravis · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03751709Phase 1 · completed Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06763302NA · not yet recruiting NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06658938NA · not yet recruiting Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649422not yet recruiting Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study · 141 trials list this drug (84 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03340766Phase 1 · completed Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) · 141 trials list this drug (84 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607419Phase 2/Phase 3 · recruiting Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541083Phase 2 · active not recruiting Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults. · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557110Phase 2 · completed Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554626Phase 2 · recruiting Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06438796Phase 2 · not yet recruiting Blinatumomab Maintenance After Allo-HSCT · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02000427Phase 2 · completed Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02187354no longer available Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04524455Phase 1 · completed Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04554485Phase 2 · completed Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06250959Phase 2 · recruiting RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL. · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339775Phase 4 · recruiting Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013167Phase 3 · terminated Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961881Phase 1 · completed A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma · 141 trials list this drug (84 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04785547Phase 2 · terminated ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT · 141 trials list this drug (84 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03072771Phase 1 · completed Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) · 141 trials list this drug (84 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06125106Phase 1 · unknown Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06111625Phase 2 · unknown Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL · 141 trials list this drug (84 active) | — | — | Lymphoid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06075212unknown Immune Reconstitution After Allo-HSCT and Blinatumomab · 141 trials list this drug (84 active) | — | — | Lymphoid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06075238Phase 2 · not yet recruiting Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT · 141 trials list this drug (84 active) | — | — | Lymphoid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05837689unknown Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation · 141 trials list this drug (84 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03109093Phase 2 · completed Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121534Phase 2 · terminated Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation · 141 trials list this drug (84 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03476239Phase 3 · completed Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02807883Phase 2 · completed Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412306Phase 1/Phase 2 · completed Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03518112Phase 2 · terminated Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05559450Phase 2 · unknown Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03523429Phase 2 · terminated PETHEMA-BLIN-01/PET069014 (BLIN-01) · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604691Phase 1 · unknown Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD) · 141 trials list this drug (84 active) | — | — | Childhood B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04448834Phase 2 · withdrawn Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044560Phase 2 · terminated Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant · 141 trials list this drug (84 active) | — | — | Acute Undifferentiated Leukemia,Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04746209Phase 2 · recruiting Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04334993Phase 2 · unknown Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03709719Phase 2 · active not recruiting Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Adult B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03605589Phase 1 · withdrawn Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma · 141 trials list this drug (84 active) | — | — | B-Cell Malignant Neoplasm,Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723342NA · unknown Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot · 141 trials list this drug (84 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02910063Phase 2/Phase 3 · completed Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL · 141 trials list this drug (84 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688983Phase 2 · unknown Study in Adult Ph-positive ALL · 141 trials list this drug (84 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023878Phase 2 · completed Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298412Phase 2 · terminated Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) · 141 trials list this drug (84 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03628053Phase 3 · withdrawn Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01207388Phase 2 · completed Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173430early Phase 1 · terminated Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma · 141 trials list this drug (84 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02744768Phase 2 · unknown D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01466179Phase 2 · completed Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01209286Phase 2 · completed Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01471782Phase 1/Phase 2 · completed Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01741792Phase 2 · completed Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) · 141 trials list this drug (84 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00560794Phase 2 · completed Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) · 141 trials list this drug (84 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274742Phase 1 · completed Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL · 141 trials list this drug (84 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538096Phase 1 · withdrawn A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma · 141 trials list this drug (84 active) | — | — | B-Cell Malignant Neoplasm,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00676871Phase 1/Phase 2 · withdrawn A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL) · 141 trials list this drug (84 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |